RESULTS: Maternal mortality rates in Maryland are increasing. When stratified into social and pregnancy related categories, maternal death due to social factors is rising with substance abuse as the leading cause of death within this category (Graph 1). Pregnancy-related causes of mortality are also increasing, albeit proportionally, with thrombotic PE and hemorrhage as the leading etiologies (Graph 2). When analyzed as percentage of cumulative maternal deaths, 5-year averages of combined social-related causes ('00-'04 8%, '05-'09 29%, '10-'15 36%) and combined pregnancy-related causes ('00-'04 7%, '05-'09 14%, '10-'15 21%) are both rising rapidly. CONCLUSION: As national and state efforts aim to reduce maternal mortality by targeting preventable causes of death such as hemorrhage, PIH, and thromboembolic events, Maryland appears to have rising rates of maternal mortality in these specific categories. Proportional increases among these causes of pregnancy-related mortality may suggest that rising rates are due to multiple factors rather than any specific etiology. As the rate of social-related maternal death increases, the rate of substance abuse mortality is rising even more rapidly (slope of the blue line, graph 1). These increases in maternal death due to pregnancy-related, social-related, and substance abuse etiologies in particular warrant further attention to reduce possibly preventable maternal mortality.
245 Severe maternal morbidity associated with hypertensive disorders in Washington state Catherine M. Albright, Laura Sienas, Suzan Walker, Jane Hitti University of Washington Medical Center, Seattle, WA OBJECTIVE: Hypertensive (HTN) disorders during pregnancy have been shown to increase risk for severe maternal morbidity (SMM) in a tertiary care center. The objective was to evaluate the association between HTN disorders and SMM in a large, population-based cohort without referral bias. We hypothesized that there would be a dose-response relationship between HTN and SMM and that this association would be modified by race/ethnicity. STUDY DESIGN: We performed a retrospective cohort study, analyzing de-identified patient-level rates of SMM diagnoses and procedures for women who delivered at all non-military hospitals in Washington state from 10/2015-9/2016. Data were obtained from the Washington State Comprehensive Hospital Abstract Reporting System (CHARS) which includes inpatient diagnosis, procedure, and discharge information derived from hospital billing systems. SMM and HTN disorders were determined from pre-specified International Classification of Disease diagnosis and procedure codes. Clinical and demographic information was compared by SMM. Odds ratios (OR) and 95% confidence intervals (CI) were calculated to evaluate the association of HTN disorders and SMM. RESULTS: Of 76,965 deliveries in 61 hospitals, 983 patients (1.3%) had SMM diagnoses or procedures. 533 patients (0.7%) had transfusion only. Women with any HTN disorder differed compared to those without by age, race/ethnicity, multiple gestation, preterm delivery, diabetes, and mode of delivery. Women with any HTN disorder had a significantly higher risk of experiencing SMM compared to women without (3.5 vs. 1.0%, OR 3.7, 95% CI 3.2-4.2, p<0.01). After adjusting for age, race/ethnicity, and diabetes, when compared to normotensive women, women with gestational HTN, chronic HTN, preeclampsia without severe features (SF), and preeclampsia with SF all were more likely to experience SMM (Table) . The association between any HTN disorder and SMM is modified by maternal race/ethnicity, with Hispanic women with a HTN disorder having the highest overall odds of experiencing SMM (Figure) . CONCLUSION: In Washington State, HTN disorders of pregnancy are associated with SMM in a dose-dependent fashion. The effect of HTN disorders on SMM is increased among Black and Hispanic women compared to other races and ethnicities. Recognition and management of HTN, especially in minority populations, may help to decrease the rates of SMM and address racial disparities in maternal reproductive health outcomes.
246 Validation of a pre-delivery risk stratification system for postpartum hemorrhage OBJECTIVE: Postpartum hemorrhage (PPH) remains a substantial cause of maternal morbidity and mortality. Pre-delivery risk stratification is a method to identify women at risk, in order to increase readiness and reaction when hemorrhage occurs. While several risk stratification systems exist, they have not been validated in the literature. STUDY DESIGN: This is a prospective nested case control study from September 2016 to April 2018 of 5326 deliveries. During this time, women were classified based on pre-delivery PPH risk (Figure 1) , which was adapted for our institution from the California maternal quality care collaborative PPH toolkit. All deliveries had blood loss calculated quantitatively during this time period. Women who had a PPH were compared to women without PPH, defined based on the ACOG definition of blood loss >1000cc for both a vaginal and cesarean deliveries. RESULTS: During this time period 537 (10%) women had a PPH. Of the women with PPH 126 (23%) required blood transfusion. Results are displayed in table 1. The majority of women having a PPH were classified as low risk. While this risk stratification system was not sensitive for detecting PPH, it was highly specific. Women classified with >1 medium risk factor (medium "plus") or high risk were significantly more likely to have a PPH and require blood transfusion. CONCLUSION: This pre-delivery risk stratification system for PPH risk identified women at risk for PPH with high specificity. However, many women with PPH were in the low risk category. While risk stratification systems may increase awareness for PPH, providers should remain vigilant even in women at "low risk" for PPH.
